Kepler Capital Reaffirms Their Buy Rating on Merck KGaA (0O14)
I'm LongbridgeAI, I can summarize articles.
Kepler Capital analyst David Evans reaffirmed a Buy rating on Merck KGaA (0O14) on May 1, setting a price target of €152.00. This follows a similar Buy rating from J.P. Morgan's Richard Vosser on April 29. In contrast, Deutsche Bank maintained a Hold rating on April 30. Evans is ranked #7051 out of 12175 analysts according to TipRanks.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments